The Europe Protein Chip Market would witness market growth of 8.69% CAGR during the forecast period (2021-2027).
Proteomics refers to the protein expression profiling under which proteins are determined in the lysate of a specific cell. In addition, protein functional analysis includes the recognition of protein-protein interactions, small molecule targets, protein–phospholipid interactions, enzymatic substrates, especially the substrates of kinases, and receptor ligands. Antibody characterization refers to the identification of specificity, cross-reactivity, and mapping epitopes. In addition, treatment development includes the making of antigen-specific therapies for cancer, autoimmunity, and allergies; the recognition of little molecule targets, which can possibly be utilized as new drugs.
The strong healthcare infrastructure of various nations in the region is one of the crucial factors bolstering the growth of the regional Protein Chip Market.
Additionally, the rising prevalence of chronic diseases, especially cancer is creating the demand for Protein Chip Markets in the regional market. It is because Protein Chip Markets help in the diagnosis of cancer. These chips can be customized by the manufacturers as per the requirements of the customers and provide high effectiveness and reliability. Due to this, the demand for Protein Chip Markets would increase in the region over the forecast period.
The Germany market dominated the Europe Protein Chip Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $77.1 million by 2027. The UK market is anticipated to grow at a CAGR of 7.6% during (2021 - 2027). Additionally, The France market would witness a CAGR of 10% during (2021 - 2027).
Based on End User, the market is segmented into Pharmaceuticals and Biotechnology Sector, Academic & Research Institutes, Diagnostic Laboratories and Hospitals and Clinics. Based on Technology, the market is segmented into Analytical Microarrays, Functional Protein Microarrays and Reverse Phase Protein Microarrays. Based on Application, the market is segmented into Diagnostics, Proteomics and Antibody Characterization. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Protein Chip Market Size will Hit $1,292.5 Million by 2027, at a CAGR of 9.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., RayBiotech Life, Inc., Quotient limited, Danaher Corporation, Arrayit Corporation, Merck Group, and Illumina, Inc.
By End User
By Technology
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
